Protective effects of silymarin against acetaminophen-induced hepatotoxicity and nephrotoxicity in mice

Toxicology and Industrial Health

Volumn 32, Issue 4, 2016, Pages 589-600

  Bektur, Nuriye Ezgi ^a   Sahin, Erhan ^a   Baycu, Cengiz ^a   Unver, Gonul ^a  

^a ESKISEHIR OSMANGAZI UNIVERSITY   (Turkey)

Author keywords

Acetaminophen; hepatotoxicity; kidney toxicity; nitric oxide; silymarin

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CREATININE; NITRIC OXIDE; PARACETAMOL; SILYMARIN; ANTIOXIDANT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BODY WEIGHT; BOWMAN CAPSULE; CELL DEATH; CELL INFILTRATION; CELL SWELLING; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DRUG EFFECT; FEMALE; GLOMERULUS CAPILLARY; LIVER PROTECTION; LIVER TOXICITY; MOUSE; NEPHROTOXICITY; NONHUMAN; RENAL PROTECTION; SINGLE DRUG DOSE; UREA NITROGEN BLOOD LEVEL; ACUTE KIDNEY FAILURE; ANIMAL; CHEMICALLY INDUCED; DIAGNOSTIC IMAGING; DRUG EFFECTS; KIDNEY; KIDNEY FUNCTION TEST; LIVER; METABOLISM; PATHOLOGY; TOXIC HEPATITIS;

ACETAMINOPHEN; ACUTE KIDNEY INJURY; ANIMALS; ANTIOXIDANTS; CHEMICAL AND DRUG INDUCED LIVER INJURY; FEMALE; KIDNEY; KIDNEY FUNCTION TESTS; LIVER; MICE; NITRIC OXIDE; SILYMARIN;

EID: 84962384777     PISSN: 07482337     EISSN: 14770393     Source Type: Journal    
DOI: 10.1177/0748233713502841     Document Type: Article

References (77)

1. Abdelmeguid NE, Chmaisse HN, Zeinab NSA, (2010) Protective effect of silymarin on cisplatin-induced nephrotoxicity in rats. Pakistan Journal of Nutrition 9: 624-636.
2. Agarwal R, Agarwal C, Ichikawa H, (2006) Anticancer potential of silymarin: from bench to bed side. Anticancer Research 26: 4457-4498.
3. Aristatile B, Al-Numair KS, Veeramani C, Pugalendi KV, (2009) Effect of carvacrol on hepatic marker enzymes and antioxidant status in d -galactosamine-induced hepatotoxicity in rats. Fundamental and Clinical Pharmacology 23: 757-765.
4. Bissell MD, Gores GJ, Laskin DL, Hoofnagle JH, (2001) Drug induced liver injury: Mechanisms and test systems. Hepatology 33: 1009-1013.
5. Blazka ME, Elwell MR, Holladay SD, Wilson RE, Luster MI, (1996) Histopathology of acetaminophen-induced liver changes: role of interleukin 1α and tumor necrosis factor alpha. Toxicologic Pathology 24 (2): 181-189.
6. Borsari M, Gabbi C, Ghelfi F, Grandi R, Saladini M, Severi S, et al. (2001) Silybin, a new iron-chelating agent. Journal of Inorganic Biochemistry 85: 123-129.
7. Cecen E, Dost T, Culhaci N, Karul A, Ergur B, Birincioglu M, (2011) Protective effects of silymarin against doxorubicin-induced toxicity. Asian Pasific Journal Of Cancer Prevention 12: 2697-2704.
8. Chtourou Y, Garoui E, Boudawara T, Zeghal N, (2012) Therapeutic efficacy of silymarin from milk thistle in reducing manganese-induced hepatic damage and apoptosis in rats. Human and Experimental Toxicology 32: 70-81.
9. Clemens MG, (2003) Nitric oxide in liver injury. Hepatology 30: 1-5.
10. Cortas NK, Wakid NW, (1990) Determination of inorganic nitrate in serum and urine by a kinetic cadmium-reduction method. Clinical Chemistry 36: 1440-1443.
11. Das J, Ghosh J, Manna P, Sil PC, (2010) Taurine protects acetaminophen-induced oxidative damage in mice kidney through APAP urinary excretion and CYP2E1 inactivation. Toxicology 269: 24-34.
12. Davis DC, Potter WZ, Jollow DJ, Mitchell JR, (1974) Species differences in hepatic glutathione depletion, covalent binding and hepatic necrosis after acetaminophen. Life Sciences 14: 2099-2109.
13. De Groot H, Raven U, (1998) Tissue injury by reactive oxygen species and the protective effects of flavonoids. Fundamental and Clinical Pharmacology 12: 249-255.
14. Doehmer J, Tewesa B, Klein KU, (2008) Assessment of drug-drug interaction for silymarin. Toxicology in Vitro 22: 610-617.
15. Drotman R, Lawhan G, (1978) Serum enzymes are indications of chemical induced liver damage. Drug and Chemical Toxicology 1: 163-171.
16. El-Shitanya NA, El-Haggarb S, El-Desoky K, (2008) Silymarin prevents adriamycin-induced cardiotoxicity and nephrotoxicity in rats. Food and Chemical Toxicology 46: 2422-2428.
17. Eminzade S, Uraz F, Izzettin FV, (2008) Silymarin protects liver against toxic effects of anti-tuberculosis drugs in experimental animals. Nutrition and Metabolism (. Lond.) 5: 18.
18. Fuhr U, Beckmann-Knopp S, Jetter A, Lück H, Mengs U, (2007) The effect of silymarin on oral nifedipine pharmacokinetics. Planta Medica 73: 1429-1435.
19. Gamalel-din AM, Mostafa AM, Al-Shabanah OA, Al-Bekairi AM, Nagi MN, (2003) Protective effect of Arabic gum against acetaminophen-induced hepatotoxicity in mice. Pharmacological Research 48 (6): 631-635.
20. Garba SH, Sambo N, Bala U, (2009) The effect of the aqueous extract of Kohautia grandiflora on paracetamol induced liver damage in albino rats. Nigerian Journal of Physiological Sciences 24 (1): 17-23.
21. Gardner CR, Heck DE, Yang CS, Thomas PE, Zhang X, Degeorge GL, et al. (1998) Role of nitric oxide in acetaminophen-induced hepatotoxicity in the rat. Hepatology 26: 748-754.
22. Gu J, Cui H, Behr M, Zhang L, Zhang Q, Yang W, et al. (2005) In vivo mechanisms of tissue-selective drug toxicity: effects of liver-specific knockout of the NADPH-cytochrome P450 reductase gene on acetaminophen toxicity in kidney, lung and nasal mucosa. Molecular Pharmacology 67: 623-630.
23. Gujral JS, Knight TR, Farhood A, (2002) Mode of cell death after acetaminophen overdose in mice: apoptosis or oncotic necrosis? Toxicological Sciences 67: 322-328.
24. Han Y, Guo D, Chen Y, (2009) Effect of silymarin on the pharmacokinetics of losartan and its active metabolite E-3174 in healthy Chinese volunteers. European Journal of Clinical Pharmacology 65: 585-591.
25. Hau DK, Wong RS, Cheng GY, Wong W, Tong S, Chan Kit K, et al. (2010) Novel use of silymarin as delayed therapy for acetaminophen-induced acute hepatic injury. Forschende Komplementärmedizin 17: 209-213.
26. Havsteen B, (1983) Flavonoids, a class of natural products of high pharmacological potency. Biochemical Pharmacology 32: 1141-1148.
27. Helms RA, Quan DJ, (2006) Textbook of Therapeutics: Drug and Disease Management. 8th ed. Pennsylvania, USA: Lippincott Williams & Wilkins.
28. Hensley K, Robinson K, Gabbita SP, Salsman S, Floyd RA, (2000) Reactive oxygen species, cell signaling and cell injury. Free Radical Biology and Medicine 28: 1456-1462.
29. Hinson JA, Roberts DW, James LP, (2010) Mechanisms of acetaminophen-induced liver necrosis. Handbook of Experimental Pharmacology 196: 369-405.
30. Jaeschke H, (2000) Reactive oxygen and mechanisms of inflammatory liver injury. Journal of Gastroenterology and Hepatology 15: 718-724.
31. Jaeschke H, Knighta T, Bajta M, (2003) The role of oxidant stress and reactive nitrogen species in acetaminophen hepatotoxicity. Toxicology Letters 144: 279-288.
32. James LP, Mayeux PR, Hinson JA, (2003) Aceta-minophen-induced hepatotoxicity. Drug Metabolism and Disposition 31: 1499-1506.
33. Jancová P, Anzenbacherová E, Papousková B, Lemr K, Luzná P, Veinlichová A, et al. (2007) Silybin is metabolized by cytochrome P450 2C8 in vitro. Drug Metabolism and Disposition 35: 2035-2039.
34. Karimi G, Ramezani M, Tahoonian Z, (2005) Cisplatin nephrotoxicity and protection by milk thistle extract in rats. eCAM 2: 383-386.
35. Kasap B, Türkmen M, Alaygut D, Soylu A, Kavukçu S, (2011) Acetaminophen induced nephrotoxicity in an adolescent girl. Turkish Pediatrics Archive 46: 334-336.
36. Kren V, Walterova D, (2005) Silybin and silymarin-new effects and applications. Biomedical Papers 149: 29-41.
37. Lazerow SK, Abdi MS, Lewis JH, (2005) Drug-induced liver disease 2004. Current Opinion Gastroenterology 21: 283-292.
38. Lee WM, Squires RH Jr, Nyberg SL, Doo E, Hoofnagle JH, (2008) Acute liver failure: summary of a workshop. Hepatology 47: 1401-1415.
39. Lindberg G, Iso H, Rastam L, Lundblad A, (1997) Serum sialic acid and its correlates in community samples from Akita, Japan, and Minneapolis, USA. Intertional Journal of Epidemiology 26: 58-63.
40. Lorz C, Justo P, Sanz A, Subira D, Egido J, Ortiz A, (2004) Paracetamol-induced renal tubular injury: a role for ER stress. Journal of the American Society of Nephrology 15: 380-389.
41. Manna SK, Mukhopadhyay A, Van NT, (1999) Silymarin suppresses TNF-induced activation of NF-kB, c-Jun N-terminal kinase and apoptosis. Journal of Immunology 163: 6800-6809.
42. Marotta F, Yadav H, Gumaste U, Helmy Jain S, Minelli E, (2009) Protective effect of a phytocompound on oxidative stress and DNA fragmentation against paracetamol-induced liver damage. Annals of Hepatology 8: 50-56.
43. Mora A, Paya M, Rios J, Alcaraz M, (1990) Structure activity relationships of polymetoxyflavones and other flavonoids as inhibitors of non-enzymatic lipid peroxidation. Biochemical Pharmacology 40: 793-794.
44. Muzes G, Deak G, Lang I, Nékám K, Niederland V, Fehér J, (1990) Effects of silymarin (Legalon) therapy on the antioxidant defense mechanism and lipid peroxidation in alcoholic liver disease. Orvosi Hetilap 131: 863-866.
45. Myers RP, Shaheen AA, Li B, Dean S, Quan H, (2008) Impact of liver disease, alcohol abuse, and unintentional ingestions on the outcomes of acetaminophen overdose. Clinical Gastroenterology and Hepatology 6: 918-925.
46. Nakae D, Yamamoto K, Yoshiji H, Kinugasa T, Maruyama H, Farber JL, et al. (1990) Liposome-encapsulated superoxide dismutase prevents liver necrosis induced by acetaminophen. American Journal of Pathology 136: 787-795.
47. Nirala SK, Bhadauria M, (2008) Propolis reverses acetaminophen induced acute hepatorenal alterations: a biochemical and histopathological approach. Archives of Pharmacal Research 31: 451-461.
48. Olaleye MT, Adegboye OO, Akindahunsi AA, (2006) Alchornea cordifolia extract protects wistar albino rats against acetaminophen-induced liver damage. African Journal of Biotechnology 5 (24): 2439-2445.
49. Park K, Dalton-Brown E, Hirst C, Williams DP, (2006) Selection of new chemical entities with decreased potential for adverse drug reactions. European Journal of Pharmacology 549: 1-8.
50. Patel N, Joseph C, Corcoran GB, Ray SD, (2010) Silymarin modulates doxorubicin-induced oxidative stress, Bcl-xL and p53 expression while preventing apoptotic and necrotic cell death in the liver. Toxicology and Applied Pharmacology 245: 143-152.
51. Pessayre D, (1995) Role of reactive metabolites in drug-induced hepatitis. Journal of Hepatology 23: 16-24.
52. Pradhan SC, Girish C, (2006) Hepatoprotective herbal drug, silymarin from experimental pharmacology to clinical medicine. Indian Journal of Medical Research 124: 491-504.
53. Qin R, Zhang J, Li C, Zhang X, Xiong A, Huang F, et al. (2012) Protective effects of gypenosides against fatty liver disease induced by high fat and cholesterol diet and alcohol in rats. Archives of Pharmacal Research 35: 1241-1250.
54. Rajkapoor B, Venugopal Y, Anbu J, Harikrishnan N, Gobinath M, Ravichandran V, (2008) Protective effect of Phyllanthus polyphyllus on acetaminophen induced hepatotoxicity in rats. Pakistan Journal of Pharmacautical Sciences 21 (1): 57-62.
55. Ramachandran V, Saravanan R, Raja B, (2011) Attenuation of oxidative stress by syringic acid on acetaminophen-induced nephrotoxic rats. Comparative Clinical Pathology 21: 1559-1564.
56. Rastogi R, Srivastava A, Rastogi A, (2001) Long term effect of aflatoxin B1 on lipid peroxidation in rat liver and kidney: effect of picroliv and silymarin. Phytotherapy Research 15: 307-310.
57. Raucy JL, Lasker JM, Lieber CS, Black M, (1989) Acetaminophen activation by human liver cytochromes P450IIE1 and P450IA2. Archives of Biochemicals and Biophysics 271: 270-283.
58. Ray SD, Kamendulis LM, Gurule MW, Yorkin RD, Corcoran GB, (1993) Ca2+ antagonists inhibit DNA fragmentation and toxic cell death induced by acetaminophen. The Journal of the Federation of American Societies for Experimental Biology 7: 453-463.
59. Ray SD, Patel D, Wong V, Bagchi D, (2000) In vivo protection of dna damage associated apoptotic and necrotic cell deaths during acetaminophen-induced nephrotoxicity, amiodarone-induced lung toxicity and doxorubicin-induced cardiotoxicity by a novel IH636 grape seed proanthocyanidin extract. Research Communications in Molecular Pathology and Pharmacology 107: 137-166.
60. Sailer R, Meier R, Brignoli R, (2001) The use of silymarin in the treatment of liver diseases. Drugs 61: 2035-2063.
61. Saliou C, Rihn B, Cillard J, (1998) Selective inhibition of NF-kB activation by the flavonoid hepatoprotector silymarin in HepG2. Evidence for different activating pathways. FEBS Letters 440: 8-12.
62. Sener G, Sehirli AO, Cetinel S, Yeǧen BG, Gedik N, Ayanoǧlu-Dülger G, (2005) Protective effects of MESNA (2-mercaptoethane sulphonate) against acetaminophen-induced hepatorenal oxidative damage in mice. Journal of Applied Toxicology 25: 20-29.
63. Senturk H, Kabay S, Bayramoglu G, Ozden H, Yaylak F, Yucel M, et al. (2008) Silymarin attenuates the renal ischemia/reperfusion injury-induced morphological changes in the rat kidney. World Journal of Urology 26: 401-407.
64. 2+ accumulation and early DNA fragmentation with cell death. Toxicology and Applied Pharmacology 111: 242-254.
65. Singh D, Chander V, Chopra K, (2005) Protective effect of catechin on ischemiareperfusion-induced renal injury in rats. Pharmacological Reports 57: 70-76.
66. Sonnenbichler J, Zetl I, (1986) Biochemical effects of the flavonolignan silibinin on RNA, protein, and DNA synthesis in rat liver. Progress in Clinical and Biological Research 213: 319-331.
67. Thabrew M, Joice P, (1987) A comparative study of the efficacy of Pavetta indica and Osbeckia octanda in the treatment of liver dysfunction. Planta Medica 53: 239-241.
68. Thummel KE, Lee CA, Kunze KL, Nelson SD, Slattery JT, (1993) Oxidation of acetaminophen to N -acetyl- p -aminobenzoquinone imine by human CYP3A4. Biochemical Pharmacology 45: 1563-1569.
69. Varzi HEN, Morovvati SH, Avizeh R, Shahriari A, Givi ME, (2007) Effect of silymarin and vitamin E on gentamicin-induced nephrotoxicity in dogs. Journal of Veterinary Pharmacology and Therapeutics 30: 477-481.
70. Velussi M, Cernigoi AM, De Monte A, Dapas F, Caffau C, Zilli M, (1997) Long-term (12 months) treatment with an anti-oxidant drug (silymarin) is effective on hyperinsulinemia, exogenous insulin need and malondialdehyde levels in cirrhotic diabetic patients. Journal of Hepatology 26: 871-879.
71. Venkataramanan R, Ramachandran V, BJ KomoroskI, (2000) Thistle, a herbal supplement, decreases the activity of CYP3A4 and uridine diphosphoglucuronosyl transferase in human hepatocyte cultures. Drug Metabolism and Disposition 28: 1270-1273.
72. Waters E, Wang JH, Redmond HP, Wu DQ, Kay E, Bouchier-Hayes D, (2001) Role of taurine in preventing acetaminophen-induced hepatic injury in the rat. American Journal of Physiology-Gastrointestinal and Liver Physiology 280: 1274-1279.
73. Yokozawa T, Dong E, (2001) Role of ginsenoside-Rd in cisplatin-induced renal injury: special reference to DNA fragmentation. Nephrology 89: 433-438.
74. Zhao B, (2005) Natural antioxidants for neurodegenerative diseases. Molecular Neurobiology 31: 283-294.
75. Zhao L, Pickering G, (2011) Paracetamol metabolism and related genetic differences. Drug metabolism reviews 43: 41-52.
76. Zhao J, Agarwal R, (1999) Tissue distribution of silibinin, the major active constituent of silymarin, in mice and its association with enhancement of phase II enzymes: implications in cancer chemoprevention. Carcinogenesis 20: 2101-2108.
77. Zuber R, Modriansky M, Dvorak Z, (2002) Effect of silybin and its congeners on human liver microsomal cytochrome P450 activities. Phytotherapy Research 16: 632-638.